Published in Gene Therapy Weekly, December 28th, 2000
The article was authored by a team of scientists including David Klatzmann, MD, PhD, an Avax consultant, and covers preclinical studies conducted at Pierre et Marie Curie University, Groupe Hospitalier Pitie-Salpetriere, Centre National de la Recherche Scientifique, and at Laboratoire de Virologies Experimentale, Institut Pasteur, all in Paris, France ("Preservation of graft-versus-infection after suicide gene therapy for prevention of graft-versus-host disease," Human Gene...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.